BCS Wealth Management
AUPH icon

BCS Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

BCS Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$196K Hold
12,083
– – 0.03% 265
2026
Q2 		$205K Hold
12,083
– – 0.04% 266
2026
Q1 		$179K Sell
12,083
-12,083
-50% -$177K 0.04% 247
2025
Q4 		$385K Buy
24,166
+11,996
+99% +$170K 0.04% 254
2025
Q3 		$134K Hold
12,170
– – 0.03% 246
2025
Q2 		$103K Hold
12,170
– – 0.02% 263
2025
Q1 		$98K Hold
12,170
– – 0.03% 243
2024
Q4 		$109K Hold
12,170
– – 0.03% 255
2024
Q3 		$89K Hold
12,170
– – 0.04% 167
2024
Q2 		$69K Hold
12,170
– – 0.03% 155
2024
Q1 		$61K Hold
12,170
– – 0.02% 235
2023
Q4 		$109K Hold
12,170
– – 0.04% 219
2023
Q3 		$95K Hold
12,170
– – 0.04% 198
2023
Q2 		$118K Buy
+12,170
New +$126K 0.09% 113
2023
Q1 		– Sell
-11,170
Closed -$48K – 163
2022
Q4 		$48K Buy
11,170
+1,000
+10% +$5.8K 0.02% 189
2022
Q3 		$76K Buy
+10,170
New +$88K 0.04% 176

Other funds holding AUPH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

BCS Wealth Management's AUPH Position: Q3 2026 in Review

BCS Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2026 at 12,083 shares worth $196K. The position accounts for 0.03% of the portfolio, ranked #265.

BCS Wealth Management first reported a position in AUPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $385K in Q4 2025. 210 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • BCS Wealth Management held 12,083 shares of Aurinia Pharmaceuticals worth $196K as of Q3 2026.
  • BCS Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q3 2026.
  • Aurinia Pharmaceuticals made up 0.03% of BCS Wealth Management's portfolio in Q3 2026, its #265 holding.
  • BCS Wealth Management first reported a position in Aurinia Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • BCS Wealth Management's Aurinia Pharmaceuticals position peaked at $385K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on BCS Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.